EMEA-002540-PIP01-18

Key facts

Active substance
Istradefylline
Therapeutic area
Neurology
Decision number
P/0270/2019
PIP number
EMEA-002540-PIP01-18
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of Parkinson's disease
Route(s) of administration
Oral use
Contact for public enquiries
Kyowa Kirin Limited

E-mail: kkd.6002@kyowakirin.com
Tel. +1 6099 191100

Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating